TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 0 | 0 | 2 | 32 | 47 | 2 | 21 |
| S | %wins | 100 | 100 | 0 | 0 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/26/05 17:26 | 5/24/05 | PDLI | Protein Design Labs Inc/de | DE | Health | BioPrd | Biological Products, (No Diag | Sato Glen Y | CA | O | SVP,CFO | M.d | 78 | 7.83 | 33 | 10 | 2 | D | 29 | 0 | 5 | 11 | 24 | 5 | 1 | 1 | 0 | 0 | 2 | 32 | 47 | 2 | |
5/26/05 17:26 | 5/24/05 | PDLI | Protein Design Labs Inc/de | DE | Health | BioPrd | Biological Products, (No Diag | Sato Glen Y | CA | O | SVP,CFO | S.d | -198 | 19.75 | 33 | -10 | -85 | 2 | D | 29 | 0 | 5 | 11 | 24 | 5 | 1 | 1 | 0 | 0 | 2 | 32 | 47 | 2 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |